DWS ESG Biotech focuses on investing in U.S.-based biotechnology companies while also including selected pharmaceutical and medical technology firms. This portfolio is centered on businesses that drive innovation in the biotech and healthcare sectors, aiming to support companies developing cutting-edge treatments and technologies in these fields.